Thalidomide as an anti-TNF-α inhibitor: Implications for clinical use

Jeffrey D. Klausner; Victoria H. Freedman; Gilla Kaplan

doi:10.1006/clin.1996.0181

Thalidomide as an anti-TNF-α inhibitor: Implications for clinical use

Jeffrey D. Klausner, Victoria H. Freedman, Gilla Kaplan

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	219-223
Number of pages	5
Journal	Clinical Immunology and Immunopathology
Volume	81
Issue number	3
DOIs	https://doi.org/10.1006/clin.1996.0181
State	Published - Dec 1996
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Pathology and Forensic Medicine
Immunology

Access to Document

10.1006/clin.1996.0181

Cite this

@article{a50f121d135348c389004f5416f2d185,

title = "Thalidomide as an anti-TNF-α inhibitor: Implications for clinical use",

author = "Klausner, {Jeffrey D.} and Freedman, {Victoria H.} and Gilla Kaplan",

year = "1996",

month = dec,

doi = "10.1006/clin.1996.0181",

language = "English (US)",

volume = "81",

pages = "219--223",

journal = "Clinical Immunology and Immunopathology",

issn = "0090-1229",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - Thalidomide as an anti-TNF-α inhibitor

T2 - Implications for clinical use

AU - Klausner, Jeffrey D.

AU - Freedman, Victoria H.

AU - Kaplan, Gilla

PY - 1996/12

Y1 - 1996/12

UR - http://www.scopus.com/inward/record.url?scp=0030560905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030560905&partnerID=8YFLogxK

U2 - 10.1006/clin.1996.0181

DO - 10.1006/clin.1996.0181

M3 - Review article

C2 - 8938097

AN - SCOPUS:0030560905

SN - 0090-1229

VL - 81

SP - 219

EP - 223

JO - Clinical Immunology and Immunopathology

JF - Clinical Immunology and Immunopathology

IS - 3

ER -

Thalidomide as an anti-TNF-α inhibitor: Implications for clinical use

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this